The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP3522906
WO Application Number:
US2017055055
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17859077.4
WO Publication Number:
WO2018067646
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
04/10/2017
Grant date:
23/03/2022
EP Publication Date:
14/08/2019
WO Publication Date:
12/04/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
15/06/2022
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/11/2023
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
23/03/2022
EP B1 Publication Date:
23/03/2022
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
03/10/2037
Lapsed By Expiration Date:
Patent Validated Date:
21/06/2022
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
23/03/2022
Name:
Asclepix Therapeutics, Inc.
Address:
301 West 29th Street, Suite 2004, Baltimore, MD 21211, United States of America (US)
From:
23/03/2022
Name:
The Johns Hopkins University
Address:
3400 North Charles Street, BALTIMORE, MD 21218, United States of America (US)